White House prepping another exec order on drug prices

President Trump is reportedly working on another executive order targeting rising drug prices, according to Reuters. The action is specifically taking aim at reducing Medicare drug prices, cutting virtually branded prescription drugs sold to the federal program, sources told Reuters.

Trump has already drafted executive orders taking rising healthcare costs into the hands of the White House. Recently, Trump was reported to be working on an order to declare a favored nations clause for drug prices, which would ensure the U.S. did not pay higher prices than other countries for medications. Another recent order requires hospitals and insurers to disclose negotiated rates for healthcare services and give patients their out-of-pocket costs before procedures.

The newest order goes much further than HHS actions to lower drug prices, which include a recent proposed rule to lower prices for Medicare Part B drugs, which are typically administered in a physician’s office.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.